60 Degrees Pharmaceuticals is launching a new clinical trial at Mount Sinai Health System to test Arakoda (tafenoquine) for chronic babesiosis. This tick-borne illness is caused by Babesia parasites that infect red blood cells. The trial will focus on patients who have... Read More »